Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of
![Safety of low intensity oral anticoagulant therapy in patients with bileaflet mechanical aortic valve prosthesis: A propensity weighted study - ScienceDirect Safety of low intensity oral anticoagulant therapy in patients with bileaflet mechanical aortic valve prosthesis: A propensity weighted study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167527320307774-ga1.jpg)
Safety of low intensity oral anticoagulant therapy in patients with bileaflet mechanical aortic valve prosthesis: A propensity weighted study - ScienceDirect
![Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario | SpringerLink Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12055-019-00789-z/MediaObjects/12055_2019_789_Fig3_HTML.png)
Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario | SpringerLink
![Comparison of warfarin dosage needed to achieve target INR before and after cardiac surgery - The British Journal of Cardiology Comparison of warfarin dosage needed to achieve target INR before and after cardiac surgery - The British Journal of Cardiology](https://bjcardio.co.uk/wp-content/uploads/2016/01/table-14.png)
Comparison of warfarin dosage needed to achieve target INR before and after cardiac surgery - The British Journal of Cardiology
CorConsult Rx - #Repost from @ambcarerx ・・・ Warfarin review! INR goals for most warfarin indications are 2-3, except unless patient has a mechanical mitral valve replacement, in which the INR goal would
![Frontiers | Antithrombotic Treatment After Surgical and Transcatheter Heart Valve Repair and Replacement Frontiers | Antithrombotic Treatment After Surgical and Transcatheter Heart Valve Repair and Replacement](https://www.frontiersin.org/files/Articles/702780/fcvm-08-702780-HTML-r1/image_m/fcvm-08-702780-t001.jpg)
Frontiers | Antithrombotic Treatment After Surgical and Transcatheter Heart Valve Repair and Replacement
![PDF) LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the "LOWERING-IT" Trial PDF) LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the "LOWERING-IT" Trial](https://www.researchgate.net/profile/Ferdinando-Carlo-Sasso/publication/45090126/figure/fig1/AS:667199467446274@1536084157191/figure-fig1_Q320.jpg)
PDF) LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the "LOWERING-IT" Trial
![Chris McAloon on Twitter: "ESC 2012 Guidelines on Target INR for Mechanical Valves (note types of valve & risk factors) #CardioEd #EEGC https://t.co/wpbVk30frW https://t.co/NqUjRIqdVu" / Twitter Chris McAloon on Twitter: "ESC 2012 Guidelines on Target INR for Mechanical Valves (note types of valve & risk factors) #CardioEd #EEGC https://t.co/wpbVk30frW https://t.co/NqUjRIqdVu" / Twitter](https://pbs.twimg.com/media/DA-poORU0AMUX-X.jpg)
Chris McAloon on Twitter: "ESC 2012 Guidelines on Target INR for Mechanical Valves (note types of valve & risk factors) #CardioEd #EEGC https://t.co/wpbVk30frW https://t.co/NqUjRIqdVu" / Twitter
![Alfonso Valle on Twitter: "💡Bioprosthetic SAVR or mitral valve replacement➡️Anticoagulation with VKA to an INR of 2.5 is reasonable for 3-6 months postoperatively (Class 2b) 💡On-X AVR ➡️ INR of 1.5-2.0, starting Alfonso Valle on Twitter: "💡Bioprosthetic SAVR or mitral valve replacement➡️Anticoagulation with VKA to an INR of 2.5 is reasonable for 3-6 months postoperatively (Class 2b) 💡On-X AVR ➡️ INR of 1.5-2.0, starting](https://pbs.twimg.com/media/Epf_4bMXYAApE0c.jpg)
Alfonso Valle on Twitter: "💡Bioprosthetic SAVR or mitral valve replacement➡️Anticoagulation with VKA to an INR of 2.5 is reasonable for 3-6 months postoperatively (Class 2b) 💡On-X AVR ➡️ INR of 1.5-2.0, starting
![Proposed antithrombotic algorithm after valvular heart procedures. a... | Download Scientific Diagram Proposed antithrombotic algorithm after valvular heart procedures. a... | Download Scientific Diagram](https://www.researchgate.net/publication/324526905/figure/fig1/AS:616004577153027@1523878344456/Proposed-antithrombotic-algorithm-after-valvular-heart-procedures-a-Includes-atrial.png)
Proposed antithrombotic algorithm after valvular heart procedures. a... | Download Scientific Diagram
![Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement | Mount Sinai - New York Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement | Mount Sinai - New York](https://www.mountsinai.org/files/MSHealth/Assets/Global/Newsroom/2021/MSHS-Newsroom-StudyDesign-2col-770x420.jpg)